MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

Our Bureau

MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the treatment of atherosclerotic lesions in native coronary […]

Thalassemia Patients Group call for inclusion of patients in policy making at APPIS 2021

Our Bureau

Thalassemia Patients Advocacy Group (TPAG) stressed the importance of involving patients in the policy making at the ongoing Asia Pacific Patient Innovation Summit (APPIS), a unique collaborative partnership initiated to address the evolving capability needs of patient organizations across Asia Pacific and beyond. Themed “Co-creating patient advocacy of the future”, […]

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

Our Bureau

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as “Cipla” today announced that its subsidiary, Cipla Gulf FZ LCC (“Cipla Gulf’) is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand. As part of this strategic alliance, Cipla Gulf will be responsible […]

Astute Care ramp up the fight against COVID-19; launches fogging-based BioProtect Surface Spray Disinfectant

Our Bureau

Committed to providing superior quality and eco-friendly solutions, Astute care joins hands with Healthy Environments, an Ozland Group Company based in Australia, to bring a revolutionary hygiene science & technology and promote a healthy environment in India. The Delhi based company is launching an imported product called BioProtect Surface Spray […]

Subscribe Now